William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Synthetic Biologics Announces Public Offering of Common Stock
-
Notable Analyst Rating Changes 6/1: (C) (KO) (ABEV) Upgraded; (CLD) (JNPR) (MRTX) Downgraded
-
Pre-Open Stock Movers 06/01: (OMG) (ONTY) (ALTR) Higher; (CLVS) (CLD) (BTU) Lower (more...)
-
UPDATE: William Blair Starts Synthetic Biologics (SYN) at Outperform, Price Target $12
-
Pre-Open Stock Movers 02/10: (HOT) (KO) (GM) Higher; (BIOC) (SALE) (ALSN) Lower (more...)
-
Synthetic Biologics (SYN) Enters $20.7M Direct Offering at $1.47/Unit

